Cargando…

Adapting Imaging Protocols for PET-CT and PET-MRI for Immunotherapy Monitoring

SIMPLE SUMMARY: In this review, we discuss the possible advantages and methods to overcome potential obstacles of applying combined imaging protocols of PET-CT and PET-MRI, within the context of staging and restaging of patients under immunotherapy, in order to achieve “multi-hybrid imaging” in one...

Descripción completa

Detalles Bibliográficos
Autores principales: Beuthien-Baumann, Bettina, Sachpekidis, Christos, Gnirs, Regula, Sedlaczek, Oliver
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8657132/
https://www.ncbi.nlm.nih.gov/pubmed/34885129
http://dx.doi.org/10.3390/cancers13236019
_version_ 1784612440298749952
author Beuthien-Baumann, Bettina
Sachpekidis, Christos
Gnirs, Regula
Sedlaczek, Oliver
author_facet Beuthien-Baumann, Bettina
Sachpekidis, Christos
Gnirs, Regula
Sedlaczek, Oliver
author_sort Beuthien-Baumann, Bettina
collection PubMed
description SIMPLE SUMMARY: In this review, we discuss the possible advantages and methods to overcome potential obstacles of applying combined imaging protocols of PET-CT and PET-MRI, within the context of staging and restaging of patients under immunotherapy, in order to achieve “multi-hybrid imaging” in one single visit. ABSTRACT: Hybrid imaging with positron emission tomography (PET) in combination with computer tomography (CT) is a well-established diagnostic tool in oncological staging and restaging. The combination of PET with magnetic resonance imaging (MRI) as a clinical scanner was introduced approximately 10 years ago. Although MRI provides superb soft tissue contrast and functional information without the radiation exposure of CT, PET-MRI is not as widely introduced in oncologic imaging as PET-CT. One reason for this hesitancy lies in the relatively long acquisition times for a PET-MRI scan, if the full diagnostic potential of MRI is exploited. In this review, we discuss the possible advantages of combined imaging protocols of PET-CT and PET-MRI, within the context of staging and restaging of patients under immunotherapy, in order to achieve “multi-hybrid imaging” in one single patient visit.
format Online
Article
Text
id pubmed-8657132
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-86571322021-12-10 Adapting Imaging Protocols for PET-CT and PET-MRI for Immunotherapy Monitoring Beuthien-Baumann, Bettina Sachpekidis, Christos Gnirs, Regula Sedlaczek, Oliver Cancers (Basel) Review SIMPLE SUMMARY: In this review, we discuss the possible advantages and methods to overcome potential obstacles of applying combined imaging protocols of PET-CT and PET-MRI, within the context of staging and restaging of patients under immunotherapy, in order to achieve “multi-hybrid imaging” in one single visit. ABSTRACT: Hybrid imaging with positron emission tomography (PET) in combination with computer tomography (CT) is a well-established diagnostic tool in oncological staging and restaging. The combination of PET with magnetic resonance imaging (MRI) as a clinical scanner was introduced approximately 10 years ago. Although MRI provides superb soft tissue contrast and functional information without the radiation exposure of CT, PET-MRI is not as widely introduced in oncologic imaging as PET-CT. One reason for this hesitancy lies in the relatively long acquisition times for a PET-MRI scan, if the full diagnostic potential of MRI is exploited. In this review, we discuss the possible advantages of combined imaging protocols of PET-CT and PET-MRI, within the context of staging and restaging of patients under immunotherapy, in order to achieve “multi-hybrid imaging” in one single patient visit. MDPI 2021-11-30 /pmc/articles/PMC8657132/ /pubmed/34885129 http://dx.doi.org/10.3390/cancers13236019 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Beuthien-Baumann, Bettina
Sachpekidis, Christos
Gnirs, Regula
Sedlaczek, Oliver
Adapting Imaging Protocols for PET-CT and PET-MRI for Immunotherapy Monitoring
title Adapting Imaging Protocols for PET-CT and PET-MRI for Immunotherapy Monitoring
title_full Adapting Imaging Protocols for PET-CT and PET-MRI for Immunotherapy Monitoring
title_fullStr Adapting Imaging Protocols for PET-CT and PET-MRI for Immunotherapy Monitoring
title_full_unstemmed Adapting Imaging Protocols for PET-CT and PET-MRI for Immunotherapy Monitoring
title_short Adapting Imaging Protocols for PET-CT and PET-MRI for Immunotherapy Monitoring
title_sort adapting imaging protocols for pet-ct and pet-mri for immunotherapy monitoring
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8657132/
https://www.ncbi.nlm.nih.gov/pubmed/34885129
http://dx.doi.org/10.3390/cancers13236019
work_keys_str_mv AT beuthienbaumannbettina adaptingimagingprotocolsforpetctandpetmriforimmunotherapymonitoring
AT sachpekidischristos adaptingimagingprotocolsforpetctandpetmriforimmunotherapymonitoring
AT gnirsregula adaptingimagingprotocolsforpetctandpetmriforimmunotherapymonitoring
AT sedlaczekoliver adaptingimagingprotocolsforpetctandpetmriforimmunotherapymonitoring